263 related articles for article (PubMed ID: 22209715)
1. A selective reversible azapeptide inhibitor of human neutrophil proteinase 3 derived from a high affinity FRET substrate.
Epinette C; Croix C; Jaquillard L; Marchand-Adam S; Kellenberger C; Lalmanach G; Cadene M; Viaud-Massuard MC; Gauthier F; Korkmaz B
Biochem Pharmacol; 2012 Mar; 83(6):788-96. PubMed ID: 22209715
[TBL] [Abstract][Full Text] [Related]
2. Using a Caesalpinia echinata Lam. protease inhibitor as a tool for studying the roles of neutrophil elastase, cathepsin G and proteinase 3 in pulmonary edema.
Cruz-Silva I; Neuhof C; Gozzo AJ; Nunes VA; Hirata IY; Sampaio MU; Figueiredo-Ribeiro Rde C; Neuhof H; Araújo Mda S
Phytochemistry; 2013 Dec; 96():235-43. PubMed ID: 24140156
[TBL] [Abstract][Full Text] [Related]
3. Proteinase 3, a potent secretagogue in airways, is present in cystic fibrosis sputum.
Witko-Sarsat V; Halbwachs-Mecarelli L; Schuster A; Nusbaum P; Ueki I; Canteloup S; Lenoir G; Descamps-Latscha B; Nadel JA
Am J Respir Cell Mol Biol; 1999 Apr; 20(4):729-36. PubMed ID: 10101005
[TBL] [Abstract][Full Text] [Related]
4. Measurement of neutrophil elastase, proteinase 3, and cathepsin G activities using intramolecularly quenched fluorogenic substrates.
Korkmaz B; Attucci S; Epinette C; Pitois E; Jourdan ML; Juliano L; Gauthier F
Methods Mol Biol; 2012; 844():125-38. PubMed ID: 22262439
[TBL] [Abstract][Full Text] [Related]
5. Modulation of tissue factor and tissue factor pathway inhibitor-1 by neutrophil proteases.
Steppich BA; Seitz I; Busch G; Stein A; Ott I
Thromb Haemost; 2008 Dec; 100(6):1068-75. PubMed ID: 19132232
[TBL] [Abstract][Full Text] [Related]
6. Discriminating between the activities of human neutrophil elastase and proteinase 3 using serpin-derived fluorogenic substrates.
Korkmaz B; Attucci S; Hazouard E; Ferrandiere M; Jourdan ML; Brillard-Bourdet M; Juliano L; Gauthier F
J Biol Chem; 2002 Oct; 277(42):39074-81. PubMed ID: 12114510
[TBL] [Abstract][Full Text] [Related]
7. Design and use of highly specific substrates of neutrophil elastase and proteinase 3.
Korkmaz B; Attucci S; Moreau T; Godat E; Juliano L; Gauthier F
Am J Respir Cell Mol Biol; 2004 Jun; 30(6):801-7. PubMed ID: 14693667
[TBL] [Abstract][Full Text] [Related]
8. Reversible ketomethylene-based inhibitors of human neutrophil proteinase 3.
Budnjo A; Narawane S; Grauffel C; Schillinger AS; Fossen T; Reuter N; Haug BE
J Med Chem; 2014 Nov; 57(22):9396-408. PubMed ID: 25365140
[TBL] [Abstract][Full Text] [Related]
9. Oxidized elafin and trappin poorly inhibit the elastolytic activity of neutrophil elastase and proteinase 3.
Nobar SM; Zani ML; Boudier C; Moreau T; Bieth JG
FEBS J; 2005 Nov; 272(22):5883-93. PubMed ID: 16279952
[TBL] [Abstract][Full Text] [Related]
10. Relevance of the mouse model as a therapeutic approach for neutrophil proteinase 3-associated human diseases.
Korkmaz B; Jenne DE; Gauthier F
Int Immunopharmacol; 2013 Dec; 17(4):1198-205. PubMed ID: 23886601
[TBL] [Abstract][Full Text] [Related]
11. Tailoring elastase inhibition with synthetic peptides.
Vasconcelos A; Azoia NG; Carvalho AC; Gomes AC; Güebitz G; Cavaco-Paulo A
Eur J Pharmacol; 2011 Sep; 666(1-3):53-60. PubMed ID: 21658384
[TBL] [Abstract][Full Text] [Related]
12. A substrate-based approach to convert SerpinB1 into a specific inhibitor of proteinase 3, the Wegener's granulomatosis autoantigen.
Jégot G; Derache C; Castella S; Lahouassa H; Pitois E; Jourdan ML; Remold-O'Donnell E; Kellenberger C; Gauthier F; Korkmaz B
FASEB J; 2011 Sep; 25(9):3019-31. PubMed ID: 21670065
[TBL] [Abstract][Full Text] [Related]
13. A new proteinase 3 substrate with improved selectivity over human neutrophil elastase.
Popow-Stellmaszyk J; Wysocka M; Lesner A; Korkmaz B; Rolka K
Anal Biochem; 2013 Nov; 442(1):75-82. PubMed ID: 23911525
[TBL] [Abstract][Full Text] [Related]
14. New selective peptidyl di(chlorophenyl) phosphonate esters for visualizing and blocking neutrophil proteinase 3 in human diseases.
Guarino C; Legowska M; Epinette C; Kellenberger C; Dallet-Choisy S; Sieńczyk M; Gabant G; Cadene M; Zoidakis J; Vlahou A; Wysocka M; Marchand-Adam S; Jenne DE; Lesner A; Gauthier F; Korkmaz B
J Biol Chem; 2014 Nov; 289(46):31777-31791. PubMed ID: 25288799
[TBL] [Abstract][Full Text] [Related]
15. Inspection of the binding sites of proteinase3 for the design of a highly specific substrate.
Hajjar E; Korkmaz B; Gauthier F; Brandsdal BO; Witko-Sarsat V; Reuter N
J Med Chem; 2006 Feb; 49(4):1248-60. PubMed ID: 16480262
[TBL] [Abstract][Full Text] [Related]
16. N-Arylacyl O-sulfonated aminoglycosides as novel inhibitors of human neutrophil elastase, cathepsin G and proteinase 3.
Craciun I; Fenner AM; Kerns RJ
Glycobiology; 2016 Jul; 26(7):701-709. PubMed ID: 26850997
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of murine neutrophil serine proteinases by human and murine secretory leukocyte protease inhibitor.
Wright CD; Kennedy JA; Zitnik RJ; Kashem MA
Biochem Biophys Res Commun; 1999 Jan; 254(3):614-7. PubMed ID: 9920787
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil Protease Cleavage of Von Willebrand Factor in Glomeruli - An Anti-thrombotic Mechanism in the Kidney.
Tati R; Kristoffersson AC; Manea Hedström M; Mörgelin M; Wieslander J; van Kooten C; Karpman D
EBioMedicine; 2017 Feb; 16():302-311. PubMed ID: 28139439
[TBL] [Abstract][Full Text] [Related]
19. Differences in the substrate binding sites of murine and human proteinase 3 and neutrophil elastase.
Hajjar E; Korkmaz B; Reuter N
FEBS Lett; 2007 Dec; 581(29):5685-90. PubMed ID: 18023421
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil-derived proteinase 3 induces kallikrein-independent release of a novel vasoactive kinin.
Kahn R; Hellmark T; Leeb-Lundberg LM; Akbari N; Todiras M; Olofsson T; Wieslander J; Christensson A; Westman K; Bader M; Müller-Esterl W; Karpman D
J Immunol; 2009 Jun; 182(12):7906-15. PubMed ID: 19494315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
